Evaluating the Cost-Effectiveness of Secukinumab in Moderate-to-severe Psoriasis: a Japanese Perspective
JOURNAL OF MEDICAL ECONOMICS（2019）
Key words
Cost-effectiveness,interleukin-17a,Japan,psoriasis,secukinumab
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined